Maynard Ryan D insider trades
Maynard Ryan D has filed 14 Form 4s with the SEC that we hold, for Iovance Biotherapeutics, INC. (IOVA) (Director), Tvardi Therapeutics, Inc. (CARA) (CHIEF FINANCIAL OFFICER) and Foghorn Therapeutics Inc. (FHTX) (Chief Financial Officer). Across all of them we count 1 purchase worth $50.6K and 2 sales worth $505.9K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 50,000 shares of Iovance Biotherapeutics, INC. worth $503.0K, dated 2024-11-12. The first filing on our record is dated 2021-07-01 and the latest 2026-06-18.
Iovance Biotherapeutics, INC. (IOVA)
Tvardi Therapeutics, Inc. (CARA)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2023-02-08 | S, sale reported on Form 4 | 5,488 | $2.9K | 2024-02-12 | SEC |
Foghorn Therapeutics Inc. (FHTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1363984) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
